Retinal Gene Therapy Market

Retinal Gene Therapy: Global Industry Analysis 2018-2022 and Opportunity Assessment 2023-2033

A recent market study published by FMI on Retinal Gene Therapy offers a global industry analysis for 2018-2022 and opportunity assessment for 2023-2033. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.

Market Segmentation

By Indication:

• Leber Congenital Amaurosis (LCA)
• Stargardt Disease
• Choroideremia
• X-linked Retinitis Pigmentosa (RP)
• Others

By End User:

• Hospitals
• Academic & Research Institutes
• Ophthalmic Clinics
• Others

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

Report Chapters

Executive Summary

The executive summary of the Retinal Gene Therapy includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Retinal Gene Therapy.

Chapter 01 - Market Overview

Readers can find the detailed segmentation and definition of the Retinal Gene Therapy in this chapter, which will help to understand basic information about Retinal Gene Therapy. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Retinal Gene Therapy report.

Chapter 02 - Market Background

This chapter includes detailed analysis of the By Indication processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.

Chapter 03 - Global Retinal Gene Therapy Demand Analysis 2018-2022 and Forecast, 2023-2033

The chapter include historical market value (USD 89.9 Million) analysis (2018-2022) and current and future market value (USD 235.4 Million) and volume (9.2%) projections (2023-2033). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.

Chapter 04 - Global Retinal Gene Therapy - Pricing Analysis

Based on By Indication, the pricing analysis chapter include Regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.

Chapter 05 - Global Retinal Gene Therapy Analysis 2018-2022 and Forecast 2023-2033, By Indication

Based on By Indication, Retinal Gene Therapy is segmented into Leber Congenital Amaurosis (LCA), Stargardt Disease, Choroideremia, X-linked Retinitis Pigmentosa (RP), Others. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Indication.

Chapter 06 - Global Retinal Gene Therapy Analysis 2018-2022 and Forecast 2023-2033, By End-Use

Based on By End-Use, Retinal Gene Therapy is segmented into Hospitals, Academic & Research Institutes, Ophthalmic Clinics, Others. This section also offers market attractiveness analysis based on By End-Use. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By End-Use.

Chapter 07 - Retinal Gene Therapy Analysis 2018-2022 and Forecast 2023-2033, By Region

Based on By Region, Retinal Gene Therapy is segmented into North America, Latin America, Europe, East Asia, South Asia, Oceania and MEA. This section also offers market attractiveness analysis based on By Region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned By Region.

Chapter 08 - North America Retinal Gene Therapy Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of the Retinal Gene Therapy in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.

Chapter 09 - Latin America Retinal Gene Therapy Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Retinal Gene Therapy in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Retinal Gene Therapy in the Latin America region.

Chapter 10 - Europe Retinal Gene Therapy Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Retinal Gene Therapy in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Retinal Gene Therapy in the regional market.

Chapter 11 - East Asia Retinal Gene Therapy Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Retinal Gene Therapy in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Retinal Gene Therapy in the regional market.

Chapter 12 - South Asia Retinal Gene Therapy Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Retinal Gene Therapy in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Retinal Gene Therapy in the regional market.

Chapter 13 - Middle East and Africa Retinal Gene Therapy Analysis 2018-2022 and Forecast 2023-2033

This chapter includes a detailed analysis of the growth of Retinal Gene Therapy in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Retinal Gene Therapy in the regional market.

Chapter 14 - Key Countries Retinal Gene Therapy Analysis 2018-2022 and Forecast 2023-2033

This chapter offers insights into how the Retinal Gene Therapy is expected to grow in major countries globally.

Chapter 15 - Market Structure Analysis- Global Assessment

This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.

Chapter 16 - Competition Deep Dive (Tentative List)

This chapter includes company overview, By Indication portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Gyroscope Therapeutics (Novartis); Applied Genetic Technologies Corporation (AGTC); Spark Therapeutics; Adverum Biotechnologies; REGENXBIO Inc.; Biogen Inc.; Nightstar Therapeutics; MeiraGTx Holdings plc; GenSight Biologics; RetroSense Therapeutics; Second Sight Medical Products; Oxford Biomedica; Hemera Biosciences; Adverio Pharmaceuticals

Chapter 17 - Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Retinal Gene Therapy report.

Chapter 18 - Research Methodology

This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Retinal Gene Therapy.